We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+275.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Top Buys

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$9.09M
2
LITE icon
Lumentum
LITE
+$8.24M
3
GLW icon
Corning
GLW
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Sector Composition

Rank Sector Weight
1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SF
76
Stifel
SF
$12.9B
$887K 0.33%
11,994
-4,847
-29% -$385K
GPCR icon
77
Structure Therapeutics
GPCR
$3.89B
$880K 0.33%
18,263
+15,827
+650% +$1.08M
MYFW icon
78
First Western Financial
MYFW
$309M
$849K 0.32%
34,520
-3,139
-8% -$79.6K
TFIN icon
79
Triumph Financial Inc
TFIN
$1.87B
$847K 0.32%
+14,193
New +$887K
NBN icon
80
Northeast Bank
NBN
$1.16B
$846K 0.32%
7,529
-4,162
-36% -$470K
AKAM icon
81
Akamai
AKAM
$18B
$841K 0.31%
+7,324
New +$734K
CASH icon
82
Pathward Financial
CASH
$1.79B
$835K 0.31%
9,354
-933
-9% -$81.2K
BTDR icon
83
Bitdeer Technologies
BTDR
$2.38B
$803K 0.3%
+92,865
New +$976K
CGON icon
84
CG Oncology
CGON
$6.62B
$788K 0.29%
11,639
-704
-6% -$39.9K
GLUE icon
85
Monte Rosa Therapeutics
GLUE
$1.35B
$781K 0.29%
47,500
+25,289
+114% +$484K
EYPT icon
86
EyePoint Inc
EYPT
$1.16B
$760K 0.28%
58,995
+53,608
+995% +$802K
IVA
87
Inventiva
IVA
$1.09B
$711K 0.27%
128,099
-1,612
-1% -$9.83K
ABT icon
88
Abbott
ABT
$193B
$696K 0.26%
+6,779
New +$765K
CSIQ icon
89
Canadian Solar
CSIQ
$1.04B
$693K 0.26%
+50,000
New +$951K
NPB
90
Northpointe Bancshares
NPB
$603M
$688K 0.26%
39,875
+21,164
+113% +$372K
BZ icon
91
Kanzhun
BZ
$6.89B
$670K 0.25%
+50,000
New +$847K
HRMY icon
92
Harmony Biosciences
HRMY
$2.24B
$660K 0.25%
23,548
+13,114
+126% +$430K
FIGR
93
Figure Technology Solutions
FIGR
$7.05B
$651K 0.24%
+19,189
New +$827K
IBKR icon
94
Interactive Brokers
IBKR
$41.4B
$644K 0.24%
+9,595
New +$685K
DNTH icon
95
Dianthus Therapeutics
DNTH
$6.13B
$625K 0.23%
7,442
-2,297
-24% -$133K
CAPR icon
96
Capricor Therapeutics
CAPR
$244M
$606K 0.23%
19,933
-31,548
-61% -$841K
EWTX icon
97
CALL
Edgewise Therapeutics
EWTX
$4.69B
$591K 0.22%
+539
New +$15.5K
Q
98
Qnity Electronics Inc
Q
$29.8B
$590K 0.22%
+5,114
New +$543K
FSLR icon
99
First Solar
FSLR
$24B
$587K 0.22%
3,176
+2,783
+708% +$616K
DAR icon
100
Darling Ingredients
DAR
$10.4B
$583K 0.22%
9,658
-5,342
-36% -$263K

Similar funds

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.